BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.140
-0.029 (-0.70%)
Jun 3, 2026, 3:25 PM EST
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $72.97 million as of June 3, 2026. Its market cap has decreased by -63.50% in one year.
Market Cap
72.97M
Enterprise Value
62.55M
Revenue
37.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.14
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 72.97M, an increase of 1,428.50%. That is a compound annual growth rate of 17.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 72.97M | 14.01% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 156.07M |
| Glorywin Entertainment Group | 149.60M |
| NDT Pharmaceuticals | 111.73M |
| HST Global | 99.00M |
| Sangamo Therapeutics | 90.19M |
| ProText Mobility | 56.26M |
| Cell Source | 54.36M |
| Nuo Therapeutics | 47.92M |